期刊文献+

伊维菌素聚酯酸酐微球的制备

Preparation of ivermectin polyester anhydride microsphere
原文传递
导出
摘要 将2种聚酯酸酐(P(SA∶RA 20∶80),P(SA∶RA 30∶70))分别与伊维菌素溶于三氯甲烷中作为有机相,以聚乙烯醇水溶液为水相,用乳化溶剂挥发法制备出2种伊维菌素聚酯酸酐微球。采用光学显微镜考察所制备微球的形态及粒径,紫外分光光度法测定载药量和包封率。结果显示,制备出的P(SA∶RA 30∶70)/IVM微球的平均粒径为(72.240±24.747)μm,载药量为19.67%,包封率为87.70%。P(SA∶RA 20∶80)/IVM微球的平均粒径为(64.18±26.14)μm,载药量为17.72%,包封率为87.27%。这表明采用乳化溶剂挥发法成功制备出2种伊维菌素聚酯酸酐微球。 Microspheres loading ivermectin (IVM) were prepared by emulsion method (O/W) based on solvent evaporation. The two kinds of P(SA : RA) with SA/RA ratios of 20 - 80 and 30 = 70 were selected as zing agent. The surface croscopy, encapsulation microsphere matrix. Polyinyl acetate (PVA) was used as emulsion stabili morphology and particle size of microspheres was examined by optical mi and drug loa showed that the volume average size 24. 747) μm, drug loading was 19.67 average size of IVM/P(SA : RA 20 was 17.72% hydride ding was deter of IVM/P(SA and the enca : 80) microsph mined by UV s : RA 30 : 70) psulation efficie eres was (64. 1 pectrophotometry. The result microspheres was (72. 240 ncy was 87.70%. The volume 8±26. 14)μm, drug loading and the encapsulation efficiency was 87. 27%. So ivermectin (IVM) polyester an- ospheres were prepared by emulsified solvent evaporation.
出处 《中国兽医学报》 CAS CSCD 北大核心 2014年第2期314-318,共5页 Chinese Journal of Veterinary Science
基金 陕西省科技计划农业攻关资助项目(2012K02-04) 中国农业科学院兰州畜牧与兽药研究所农业部兽用药物创制重点实验室 甘肃省新兽药工程重点实验室开放课题资助项目(1610322011011) 西北农林科技大学国家级大学生创新基金资助项目(1210712043)
关键词 伊维菌素 聚酯酸酐 乳化溶剂挥发法 微球 ivermectin polyester anhydride emulsiied solvent evaporation microsphere
  • 相关文献

参考文献11

  • 1Ciftci K,Hincal A A,Kas H S. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly (L-lactic acid) microspheres[J].Pharm Deve Technol,1997,(02):151-160.
  • 2Gong S J,Sun S X,Sun Q S. Tablets based on compressed zein microspheres for sustained oral administration:design,pharmacokinetics,and clinical study[J].J Biomat Appl,2011,(02):195-208.
  • 3夏晓静,周建平,王翔,高蓉.伊维菌素聚乳酸微球的制备[J].中国药科大学学报,2004,35(5):429-432. 被引量:13
  • 4王敏儒,陈杖榴,冯淇辉.伊维菌素聚乳酸微球的研制及其体外释药试验[J].中国兽医科技,1999,29(8):10-12. 被引量:25
  • 5Langer R. Biomaterials in drug delivery and tissue engineering:one laboratory,s experience[J].{H}ACCOUNTS OF CHEMICAL RESEARCH,2000,(02):94-101.
  • 6Carino G P,Jacob J S,Mathiowitz E. Nanosphere based oral insulin delivery[J].J Contr Release,2000,(1/2):261-269.doi:10.1016/S0168-3659(99)00247-3.
  • 7Shikanov A,Vaisman B,Krasko M Y. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel:In vitro release and in vivo toxicity[J].J Biomed Mat Research Part A,2004,(01):47-54.
  • 8Jiang H L,Tang G P,Weng L H. In vivo degradation and biocompatibility of a new class of alternate poly(ester-anhydrides) based on aliphatic and aromatic diacids[J].J Biomat Sci-Polym Edition,2001,(12):1281-1292.
  • 9Shikanov A,Ezra A,Domb A J. Poly(sebacic acid-coricinoleic acid) biodegradable carrier for paclitaxeleffect of additives[J].J Contr Release,2005,(1/2):52-67.
  • 10刘志挺,吕竹芬,陈燕忠.溶剂蒸发法在微球制备中的应用及研究进展[J].广东药学院学报,2007,23(5):596-600. 被引量:14

二级参考文献36

  • 1刘付启荣,冯淇辉.丙硫苯咪唑控释装置及其在山羊体内的释药过程和药效研究[J].畜牧兽医学报,1993,24(6):560-565. 被引量:7
  • 2李德冠,姜丹,姜云垒,庄江兴,刘成柏,刘立东,陈霞.聚乳酸微球的制备[J].吉林大学学报(理学版),2005,43(6):842-846. 被引量:14
  • 3王亚敏,石庭森.微球制剂药物控释研究进展[J].中国药学杂志,1996,31(3):131-134. 被引量:17
  • 4徐慧斌 沈杰 等.伊维菌素长效控释丸在绵羊体内拒绝物动力学研究[J].中国兽医寄生虫病,1996,4(2):5-9.
  • 5沈正荣.5-Fu/PLG微球的制备[J].中国药学杂志,1992,27(7):408-410.
  • 6王敏儒,华南农业大学学报,1998年,15卷,6期,5页
  • 7徐慧斌,中国兽医寄生虫病,1996年,4卷,2期,5页
  • 8沈正荣,中国药学杂志,1992年,27卷,7期,408页
  • 9Ciftci K,Hincal AA,Kas HS,et al.Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres[J].Pharm Dev Technol,1997,2(2):151-160.
  • 10M Hariharan,JC Price.Solvent,emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine[J].J Microencapsulation,2002,19(1):95-109.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部